Top Institutional Investors

RICE HALL JAMES & ASSOCIATES, LLC — 13F Holdings & Portfolio

CIK 1230765 · latest 13F-HR filed 2026-08-07

Backtest portfolio

RICE HALL JAMES & ASSOCIATES, LLC manages $2.05B in 13F-reported U.S. long-equity assets across 240 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are LGND (4.15%), ACIW (2.46%), ARLO (2.45%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 14 new positions, exited 17, added to 126, and trimmed 60.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
600 WEST BROADWAY STE 1000
SAN DIEGO, CA 92101
Phone
(619) 239-9005
Filing Manager
RICE HALL JAMES & ASSOCIATES, LLC
San Diego, CA
Signatory
Janine Marquez
Chief Compliance Officer
Loading holdings…
AUM

$2.05B

Long-equity book

Holdings

240

Distinct positions

Period

2026-06-30

Filed 2026-08-07

Q/Q Activity

+14 / −17 / ↑126 / ↓60

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • LIGAND PHARMACEUTICALS INC$28.7M +50.8%
  • ESTABLISHMENT LABS HLDGS INC$17.0M +54.5%
  • TETRA TECHNOLOGIES INC DEL$11.8M +3466.6%
  • KINIKSA PHARMACEUTICALS INTL$10.7M +36.4%
  • ACI WORLDWIDE INC$9.5M +23.0%
Show all 126 →

Top Trims

  • WIX COM LTD-$9.4M -35.1%
  • CHART INDS INC-$7.2M -47.8%
  • FABRINET-$6.0M -10.8%
  • DONNELLEY FINL SOLUTIONS INC-$4.3M -11.6%
  • AMDOCS LTD-$3.5M -22.4%
Show all 60 →

New Positions

  • ASCENDIS PHARMA A/S$39.6M
  • OSHKOSH CORP$16.3M
  • PAR TECHNOLOGY CORP$6.6M
  • SHOALS TECHNOLOGIES GROUP IN$6.4M
  • ALPHATEC HLDGS INC$5.7M
Show all 14 →

Exited Positions

  • ASCENDIS PHARMA A/S$33.9M
  • AMICUS THERAPEUTIC$11.1M
  • SOLENO THERAPEUTICS INC$6.9M
  • AMPHASTAR PHARMACEUTICALS IN$3.7M
  • VITAL FARMS INC$3.1M
Show all 17 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 LIGAND PHARMACEUTICALS INC LGND 53220K504 $85.4M 4.15% 270,052 SH
2 ACI WORLDWIDE INC ACIW 004498101 $50.6M 2.46% 1,006,595 SH
3 ARLO TECHNOLOGIES INC ARLO 04206A101 $50.3M 2.45% 3,732,962 SH
4 FABRINET FN G3323L100 $49.2M 2.40% 87,577 SH
5 ESTABLISHMENT LABS HLDGS INC ESTA G31249108 $48.1M 2.34% 560,935 SH
6 XPO INC XPO 983793100 $46.2M 2.25% 224,878 SH
7 ZIFF DAVIS INC ZD 48123V102 $43.0M 2.09% 821,496 SH
8 SHIFT4 PMTS INC FOUR 82452J109 $42.5M 2.07% 874,492 SH
9 KINIKSA PHARMACEUTICALS INTL KNSA G52694109 $40.0M 1.95% 624,928 SH
10 ASCENDIS PHARMA A/S ASND K08588103 $39.6M 1.93% 148,644 SH
11 STRIDE INC LRN 86333M108 $37.9M 1.84% 438,981 SH
12 PRESTIGE CONSMR HEALTHCARE I PBH 74112D101 $32.6M 1.59% 689,692 SH
13 DONNELLEY FINL SOLUTIONS INC DFIN 25787G100 $32.5M 1.58% 775,119 SH
14 ITURAN LOCATION AND CONTROL ITRN M6158M104 $29.0M 1.41% 475,496 SH
15 MEDPACE HLDGS INC MEDP 58506Q109 $28.7M 1.39% 54,116 SH
16 ARMSTRONG WORLD INDS INC NEW AWI 04247X102 $28.4M 1.38% 177,147 SH
17 GODADDY INC GDDY 380237107 $28.1M 1.37% 330,474 SH
18 BIRKENSTOCK HOLDING PLC BIRK M2029K104 $27.1M 1.32% 629,868 SH
19 CLEAR SECURE INC YOU 18467V109 $27.0M 1.32% 485,011 SH
20 INGEVITY CORP NGVT 45688C107 $26.2M 1.28% 351,203 SH
21 WEX INC WEX 96208T104 $25.2M 1.23% 178,606 SH
22 SPORTRADAR GROUP AG SRAD H8088L103 $23.9M 1.16% 1,597,682 SH
23 LIQUIDITY SVCS INC LQDT 53635B107 $23.8M 1.16% 608,476 SH
24 FEDERAL AGRIC MTG CORP AGM 313148306 $23.5M 1.15% 118,094 SH
25 BIOCRYST PHARMACEUTICALS INC BCRX 09058V103 $23.3M 1.13% 2,332,043 SH
26 UPWORK INC UPWK 91688F104 $23.2M 1.13% 2,776,805 SH
27 GENPACT LIMITED G G3922B107 $22.9M 1.12% 833,996 SH
28 SUPERNUS PHARMACEUTICALS SUPN 868459108 $22.8M 1.11% 490,221 SH
29 VIRIDIAN THERAPEUTICS INC VRDN 92790C104 $21.6M 1.05% 1,175,906 SH
30 RADWARE LTD RDWR M81873107 $21.0M 1.02% 680,853 SH
31 ALKERMES PLC ALKS G01767105 $20.5M 1.00% 390,866 SH
32 NEXXEN INTL LTD NEXN M8T80P204 $19.7M 0.96% 2,186,838 SH
33 PROGRESS SOFTWARE CORP PRGS 743312100 $19.1M 0.93% 570,261 SH
34 QUIDELORTHO CORP QDEL 219798105 $18.6M 0.91% 1,063,559 SH
35 LEMAITRE VASCULAR INC LMAT 525558201 $18.2M 0.89% 189,907 SH
36 EURONET WORLDWIDE INC EEFT 298736109 $18.1M 0.88% 247,689 SH
37 LKQ CORP LKQ 501889208 $17.9M 0.87% 678,259 SH
38 WIX COM LTD WIX M98068105 $17.4M 0.84% 382,619 SH
39 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $16.9M 0.82% 100,195 SH
40 HARROW INC HROW 415858109 $16.5M 0.80% 387,545 SH
41 OSHKOSH CORP OSK 688239201 $16.3M 0.79% 106,011 SH
42 VAIL RESORTS INC MTN 91879Q109 $15.9M 0.78% 117,085 SH
43 ACADIA PHARMACEUTICALS INC ACAD 004225108 $15.7M 0.76% 618,887 SH
44 LCI INDS LCII 50189K103 $15.1M 0.74% 142,665 SH
45 VAREX IMAGING CORP VREX 92214X106 $15.1M 0.73% 1,445,853 SH
46 MAXIMUS INC MMS 577933104 $15.0M 0.73% 278,910 SH
47 BIOMARIN PHARMACEUTICAL INC BMRN 09061G101 $14.2M 0.69% 248,224 SH
48 TAYSHA GENE THERAPIES INC TSHA 877619106 $13.6M 0.66% 1,992,229 SH
49 BANK OZK LITTLE ROCK ARK OZK 06417N103 $13.5M 0.66% 259,433 SH
50 MIRUM PHARMACEUTICALS INC MIRM 604749101 $13.0M 0.63% 110,673 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-07 $2.05B 240 0001172661-26-003169
2026-03-31 2026-05-15 $1.80B 243 0001172661-26-002239
2025-12-31 2026-02-17 $1.82B 243 0001172661-26-000807
2025-09-30 2025-10-16 $1.83B 248 0001172661-25-004300